BR0316308A - Método para a preparação de um composto de imidazolila - Google Patents

Método para a preparação de um composto de imidazolila

Info

Publication number
BR0316308A
BR0316308A BR0316308-3A BR0316308A BR0316308A BR 0316308 A BR0316308 A BR 0316308A BR 0316308 A BR0316308 A BR 0316308A BR 0316308 A BR0316308 A BR 0316308A
Authority
BR
Brazil
Prior art keywords
hydrogen
alkyl
compound
preparation
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BR0316308-3A
Other languages
English (en)
Inventor
Jan-Maarten Verbeek
Paulus F C Van Der Meij
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay Pharmaceuticals BV
Original Assignee
Solvay Pharmaceuticals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals BV filed Critical Solvay Pharmaceuticals BV
Publication of BR0316308A publication Critical patent/BR0316308A/pt
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"MéTODO PARA A PREPARAçãO DE UM COMPOSTO DE IMIDAZOLILA". A presente invenção diz respeito a um método para a preparação de um composto de imidazolila da fórmula geral (I), em que: R~ a~ e R~ b~ cada um é separadamente (C~ 1~-C~ 6~)alquila, (C~ 1~-C~ 6~)alcoxialquila, arila ou heteroarila opcionalmente substituída; ou em que R~ a~ e R~ b~ juntos formam um outro sistema homocíclico ou heterocíclico compreendendo um ou mais anéis; R~ a~ e R~ b~ cada um é hidrogênio ou juntos formam uma ligação dupla de carbono-carbono, a dita ligação dupla de carbono-carbono opcionalmente fazendo parte de um sistema aromático; R~ c~ é hidrogênio, (C~ 1~-C~ 6~)alquila, (C~ 1~-C~ 6~)alcóxi, (C~ 1~-C~ 6~)alcoxialquila ou halogênio; R~ d~ é hidrogênio ou (C~ 1~-C~ 4~)alquila; R~ e~ é hidrogênio ou (C~ 1~-C~ 4~)alquila; m é 1 ou 2; e R~ 1~, é hidrogênio ou (C~ 1~-C~ 4~)alquila; como também seu sal de adição de ácido; caracterizado em que um composto da fórmula geral (II) é reagido com um composto da fórmula (III), em que: R é um hidrogênio, um grupo (C~ 1~-C~ 4~)alquila opcionalmente substituído por um grupo hidróxi ou um grupo arila opcionalmente substituída, R<39>, R<39><39>,e R<39><39><39> cada um individualmente é um hidrogênio, um grupo (C~ 1~-C~ 4~)alquila; seguido por uma reação com um composto da fórmula (IV), em que R~ 1~, R~ d~ e R~ e~ têm os significados definidos acima; e opcionalmente seguido por uma reação com um ácido adequado. O método de acordo com a presente invenção é especialmente útil para a preparação de ondansetron e cilansetron.
BR0316308-3A 2002-11-18 2003-11-17 Método para a preparação de um composto de imidazolila Pending BR0316308A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079838 2002-11-18
PCT/EP2003/050841 WO2004046116A1 (en) 2002-11-18 2003-11-17 Novel process for the preparation of imidazolyl compounds

Publications (1)

Publication Number Publication Date
BR0316308A true BR0316308A (pt) 2005-09-27

Family

ID=32319633

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316308-3A Pending BR0316308A (pt) 2002-11-18 2003-11-17 Método para a preparação de um composto de imidazolila

Country Status (25)

Country Link
EP (1) EP1565445B1 (pt)
JP (1) JP4611026B2 (pt)
KR (1) KR20050075026A (pt)
CN (1) CN100349873C (pt)
AR (1) AR041955A1 (pt)
AT (1) ATE340783T1 (pt)
AU (1) AU2003296762B2 (pt)
BR (1) BR0316308A (pt)
CA (1) CA2504614C (pt)
DE (1) DE60308720T2 (pt)
DK (1) DK1565445T3 (pt)
ES (1) ES2273088T3 (pt)
HK (1) HK1081188A1 (pt)
HR (1) HRP20050376A2 (pt)
IL (1) IL168258A (pt)
MX (1) MXPA05005261A (pt)
NO (1) NO330342B1 (pt)
PL (1) PL376743A1 (pt)
PT (1) PT1565445E (pt)
RU (1) RU2314296C2 (pt)
SA (1) SA03240414B1 (pt)
SI (1) SI1565445T1 (pt)
UA (1) UA79655C2 (pt)
WO (1) WO2004046116A1 (pt)
ZA (1) ZA200503425B (pt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.

Also Published As

Publication number Publication date
AR041955A1 (es) 2005-06-01
RU2005119155A (ru) 2006-01-20
CN1714082A (zh) 2005-12-28
HK1081188A1 (en) 2006-05-12
SA03240414B1 (ar) 2006-12-05
EP1565445B1 (en) 2006-09-27
UA79655C2 (en) 2007-07-10
KR20050075026A (ko) 2005-07-19
HRP20050376A2 (en) 2006-02-28
DE60308720D1 (de) 2006-11-09
DE60308720T2 (de) 2007-01-11
JP2006512322A (ja) 2006-04-13
NO330342B1 (no) 2011-03-28
PL376743A1 (pl) 2006-01-09
ZA200503425B (en) 2007-02-28
CA2504614C (en) 2010-09-28
NO20052950D0 (no) 2005-06-16
DK1565445T3 (da) 2007-01-29
NO20052950L (no) 2005-08-15
RU2314296C2 (ru) 2008-01-10
JP4611026B2 (ja) 2011-01-12
AU2003296762B2 (en) 2010-03-18
CA2504614A1 (en) 2004-06-03
AU2003296762A1 (en) 2004-06-15
PT1565445E (pt) 2007-01-31
WO2004046116A1 (en) 2004-06-03
IL168258A (en) 2010-05-31
MXPA05005261A (es) 2005-07-25
EP1565445A1 (en) 2005-08-24
ATE340783T1 (de) 2006-10-15
CN100349873C (zh) 2007-11-21
ES2273088T3 (es) 2007-05-01
SI1565445T1 (sl) 2007-02-28

Similar Documents

Publication Publication Date Title
CY1124582T1 (el) Μεθοδος παραγωγης ενωσεων που εχουν δρασης αναστολης ιντεγκρασης hiv
BRPI0818193B8 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013000868A2 (pt) derivados de pirazol [1,5a] e tieno [3,2b] pirimidina como modulares de irak4
BR112012033350A2 (pt) &#34;composição e métodos para modular a via de sinalização de wnt&#34;
BR112012028445A2 (pt) compostos de heteroarila bicíclica como moduladores de gpr119
BRPI0613403A2 (pt) tetrahidrobenzodiazepinas aril- e heteroarila-substituÍdas e uso das mesmas para bloquear a recaptaÇço de norepinefrina, dopamina e serotonina
BR112012033241A2 (pt) [1,8]naftiridinas substituídas por 2,4-diarila como inibidores de quinase para uso contra câncer
BR112013002164A2 (pt) inibidores de desmetilase com base em arilciclopropilamina de lds1 e seu uso médico
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
EA201170769A1 (ru) Органические соединения
WO2008062905A3 (en) Heteromonocyclic compound and use thereof
BR112013001365A2 (pt) processo de preparo de derivados de benzofurano substituídos na posição 5
AR047531A1 (es) Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa
ATE547411T1 (de) 3-pyrrolo-cyclohexylen-2-dihydroindolinonderiva e und anwendungen davon
BR112012014807A2 (pt) &#34;compostos adequados para o tratamento de sinucleopatias&#34;
GEP20125637B (en) Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
BRPI0810661A2 (pt) [2,6] naftiridinas úteis como inibidoras de quinase proteica.
BR112012029913A2 (pt) levoisovalespiramicina i, ii ou iii, preparações, métodos de preparação e usos dos mesmos
EA201201662A1 (ru) Дизамещенные тетрагидрофуранильные соединения в качестве антагонистов брадикининового рецептора в1
BRPI0507777A (pt) método para produzir um composto de 4-nitroimidazol
AR078683A1 (es) Compuesto de pirona y su uso para el control de plagas
BR0316308A (pt) Método para a preparação de um composto de imidazolila
BR112014007460A2 (pt) processos enanciosseletivos para pirrolidinas 3-aril-3-trifluorometil-substituídas inseticidas
BR112013011244A2 (pt) processo para a preparação de derivados e ácido 3-(6-amino-piridin-3il)-2-acrílico
EP2604261A3 (en) SCCA-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]